Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.667,29
-0,99%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hemogenyx Pharmaceuticals Plc (HEMO) Hemogenyx Pharmaceuticals Plc (HEMO) Notizie

HEMO

Hemogenyx Pharmaceuticals (HEMO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HEMO
DataOraFonteTitoloSimboloCompagnia
31/01/202510:35RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
08/01/202512:49Alliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trialLSE:HEMOHemogenyx Pharmaceuticals Plc
08/01/202508:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to raise £340,000LSE:HEMOHemogenyx Pharmaceuticals Plc
02/01/202508:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Change of Company Secretary and Registered OfficeLSE:HEMOHemogenyx Pharmaceuticals Plc
30/12/202413:01Alliance NewsAlliance NewsHemogenyx opens first clinical site for leukaemia therapy trialLSE:HEMOHemogenyx Pharmaceuticals Plc
30/12/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Opening of First Clinical SiteLSE:HEMOHemogenyx Pharmaceuticals Plc
19/12/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Ultrafast CAR-T ManufacturingLSE:HEMOHemogenyx Pharmaceuticals Plc
10/12/202417:10RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Admission of New Ordinary Shares and New ISINLSE:HEMOHemogenyx Pharmaceuticals Plc
09/12/202414:30RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Extraordinary General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
09/12/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Site Initiation Visit CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
06/12/202416:40Alliance NewsAlliance NewsTRADING UPDATES: SDX plots AIM exit; Celadon receives fundsLSE:HEMOHemogenyx Pharmaceuticals Plc
06/12/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Macrophage Delivery UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
22/11/202413:49RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Notice of Extraordinary General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
22/11/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC IRB Approval for Phase I Clinical TrialLSE:HEMOHemogenyx Pharmaceuticals Plc
11/11/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Institutional InvestmentLSE:HEMOHemogenyx Pharmaceuticals Plc
30/10/202412:09Alliance NewsAlliance NewsIN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trialLSE:HEMOHemogenyx Pharmaceuticals Plc
30/10/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Schedule for Phase I Clinical Trial OpeningLSE:HEMOHemogenyx Pharmaceuticals Plc
02/10/202412:19RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
27/09/202419:25Alliance NewsAlliance NewsHemogenyx Pharmaceuticals loss narrows amid reduced expensesLSE:HEMOHemogenyx Pharmaceuticals Plc
27/09/202416:55Alliance NewsAlliance NewsEARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrowsLSE:HEMOHemogenyx Pharmaceuticals Plc
27/09/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
09/09/202423:03Alliance NewsAlliance NewsTRADING UPDATES: Light Science Technologies wins two new contractsLSE:HEMOHemogenyx Pharmaceuticals Plc
09/09/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I Trials at MD AndersonLSE:HEMOHemogenyx Pharmaceuticals Plc
02/09/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CDX Development UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
28/08/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Presentation at CBD S&T ConferenceLSE:HEMOHemogenyx Pharmaceuticals Plc
29/07/202408:00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Macrophage-Directed Therapies Summit PresentationLSE:HEMOHemogenyx Pharmaceuticals Plc
27/06/202417:39RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Annual General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
17/06/202420:55Alliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
17/06/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Operations UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
03/06/202408:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Posting of Annual Report & Notice of AGMLSE:HEMOHemogenyx Pharmaceuticals Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HEMO

La tua Cronologia

USOTC
ADRLF
Adavale Resources (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci